These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Sacred Maya incense, copal (Protium copal - Burseraceae), has antianxiety effects in animal models. Merali Z; Cayer C; Kent P; Liu R; Cal V; Harris CS; Arnason JT J Ethnopharmacol; 2018 Apr; 216():63-70. PubMed ID: 29414121 [TBL] [Abstract][Full Text] [Related]
63. An endocannabinoid system is localized to the hypophysial pars tuberalis of Syrian hamsters and responds to photoperiodic changes. Yasuo S; Koch M; Schmidt H; Ziebell S; Bojunga J; Geisslinger G; Korf HW Cell Tissue Res; 2010 Apr; 340(1):127-36. PubMed ID: 20165884 [TBL] [Abstract][Full Text] [Related]
64. Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain. Leishman E; Cornett B; Spork K; Straiker A; Mackie K; Bradshaw HB Pharmacol Res; 2016 Aug; 110():159-172. PubMed ID: 27109320 [TBL] [Abstract][Full Text] [Related]
65. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents. Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187 [TBL] [Abstract][Full Text] [Related]
66. Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors. Bedse G; Bluett RJ; Patrick TA; Romness NK; Gaulden AD; Kingsley PJ; Plath N; Marnett LJ; Patel S Transl Psychiatry; 2018 Apr; 8(1):92. PubMed ID: 29695817 [TBL] [Abstract][Full Text] [Related]
67. Prolonged monoacylglycerol lipase blockade causes equivalent cannabinoid receptor type 1 receptor-mediated adaptations in fatty acid amide hydrolase wild-type and knockout mice. Schlosburg JE; Kinsey SG; Ignatowska-Jankowska B; Ramesh D; Abdullah RA; Tao Q; Booker L; Long JZ; Selley DE; Cravatt BF; Lichtman AH J Pharmacol Exp Ther; 2014 Aug; 350(2):196-204. PubMed ID: 24849924 [TBL] [Abstract][Full Text] [Related]
68. Diet-dependent modulation of hippocampal expression of endocannabinoid signaling-related proteins in cannabinoid antagonist-treated obese rats. Rivera P; Luque-Rojas MJ; Pastor A; Blanco E; Pavón FJ; Serrano A; Crespillo A; Vida M; Grondona JM; Cifuentes M; Bermúdez-Silva FJ; de la Torre R; de Fonseca FR; Suárez J Eur J Neurosci; 2013 Jan; 37(1):105-17. PubMed ID: 23033907 [TBL] [Abstract][Full Text] [Related]
69. Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ. Du H; Chen X; Zhang J; Chen C Br J Pharmacol; 2011 Aug; 163(7):1533-49. PubMed ID: 21501147 [TBL] [Abstract][Full Text] [Related]
70. The effects of fatty acid amide hydrolase inhibition and monoacylglycerol lipase inhibition on habit formation in mice. Gianessi CA; Groman SM; Taylor JR Eur J Neurosci; 2022 Feb; 55(4):922-938. PubMed ID: 33506530 [TBL] [Abstract][Full Text] [Related]
71. An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters. Moise AM; Eisenstein SA; Astarita G; Piomelli D; Hohmann AG Psychopharmacology (Berl); 2008 Oct; 200(3):333-46. PubMed ID: 18545985 [TBL] [Abstract][Full Text] [Related]
72. Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol. Ghafouri N; Tiger G; Razdan RK; Mahadevan A; Pertwee RG; Martin BR; Fowler CJ Br J Pharmacol; 2004 Nov; 143(6):774-84. PubMed ID: 15492019 [TBL] [Abstract][Full Text] [Related]
74. Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol. Szabo B; Urbanski MJ; Bisogno T; Di Marzo V; Mendiguren A; Baer WU; Freiman I J Physiol; 2006 Nov; 577(Pt 1):263-80. PubMed ID: 16973696 [TBL] [Abstract][Full Text] [Related]
75. Unique inhibitory synapse with particularly rich endocannabinoid signaling machinery on pyramidal neurons in basal amygdaloid nucleus. Yoshida T; Uchigashima M; Yamasaki M; Katona I; Yamazaki M; Sakimura K; Kano M; Yoshioka M; Watanabe M Proc Natl Acad Sci U S A; 2011 Feb; 108(7):3059-64. PubMed ID: 21282604 [TBL] [Abstract][Full Text] [Related]
76. Potent dual MAGL/FAAH inhibitor AKU-005 engages endocannabinoids to diminish meningeal nociception implicated in migraine pain. Della Pietra A; Krivoshein G; Ivanov K; Giniatullina R; Jyrkkänen HK; Leinonen V; Lehtonen M; van den Maagdenberg AMJM; Savinainen J; Giniatullin R J Headache Pain; 2023 Apr; 24(1):38. PubMed ID: 37038131 [TBL] [Abstract][Full Text] [Related]
78. Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents. Wiley JL; Walentiny DM; Wright MJ; Beardsley PM; Burston JJ; Poklis JL; Lichtman AH; Vann RE Eur J Pharmacol; 2014 Aug; 737():97-105. PubMed ID: 24858366 [TBL] [Abstract][Full Text] [Related]
79. Differential alteration of hippocampal excitatory synaptic transmission by cannabinoid ligands. Bajo M; Roberto M; Schweitzer P J Neurosci Res; 2009 Feb; 87(3):766-75. PubMed ID: 18816788 [TBL] [Abstract][Full Text] [Related]
80. Endocannabinoid signaling regulates the reinforcing and psychostimulant effects of ketamine in mice. Xu W; Li H; Wang L; Zhang J; Liu C; Wan X; Liu X; Hu Y; Fang Q; Xiao Y; Bu Q; Wang H; Tian J; Zhao Y; Cen X Nat Commun; 2020 Nov; 11(1):5962. PubMed ID: 33235205 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]